The report provides a detailed analysis essential for establishing a Norgestrel production plant. It encompasses all critical aspects necessary for Norgestrel production, including the cost of Norgestrel production, Norgestrel plant cost, Norgestrel production costs, and the overall Norgestrel production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Norgestrel production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Norgestrel is a synthetic steroidal progestin that is widely used as a drug in the medical and pharmaceutical industries. It is extensively used as an oral contraceptive drug used alone or in combination with ethinyl estradiol for the prevention of pregnancy in women. Moreover, it also finds its application as a medication for the treatment of endometriosis and managing menstrual disorders. Additionally, it is also used for the management of symptoms associated with hormone imbalance in various gynecological disorders.
The market of Norgestrel is largely led by its application in the medical and pharmaceutical industries as a birth control pill to prevent pregnancy in women, which remarkably promotes its market expansion. Moreover, its utilization as a medication in hormone replacement therapy for the treatment of menstrual disorders and various gynecological disorders further enhances its demand in the pharmaceutical industry. Furthermore, several factors influence industrial norgestrel procurement, such as the availability of raw materials (6-methoxy-alpha-tetralone, vinylmagnesium bromide, etc.), cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Norgestrel Production
According to the Norgestrel production plant project report, the major raw materials for Norgestrel production include 6-Methoxy-alpha-tetralone-Vinylmagnesium Bromide- 2-Ethyl-1,3-cyclopentanedione.
Manufacturing Process of Norgestrel
The extensive Norgestrel production cost report consists of the following industrial production process:
- Production from 6-methoxy-alpha-tetralone: This method of production is initiated by the reaction of 6-methoxy-alpha-tetralone with vinylmagnesium bromide to form 1,2,3,4-tetrahydro-6-methoxy-1-vinyl-1-naphthol as a product. Further, the obtained product undergoes condensation with 2-ethyl-1,3-cyclopentanedione to give a tricyclic intermediate (secosteroid), which is then cyclized through dehydration to form 13-ethylgona-1,3,5(10)-8,14-pentaene structure, followed by reduction and ethynylation to obtain Norgestrel as the final product.
Norgestrel comprises a racemic mixture of two stereoisomers, dextronorgestrel and levonorgestrel. Out of these two stereoisomers, only the levorotary enantiomer ([levonorgestrel]) is biologically active. Moreover, its activities are similar to those of a hormone, progesterone. Its molecular formula is C21H28O2, and its molecular mass is 312.4 g/mol. The compound is also known as Mirena, D-Norgestrel, or Levonorgestrel. Additionally, the IUPAC name of the compound is (8R,9S,10R,13S,14S)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one. The boiling point of the compound is 459ºC.